Loading...

InnoCan Pharma Corporation

INNPFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.16
$0.00(0.00%)

InnoCan Pharma Corporation (INNPF) Company Profile & Overview

Explore InnoCan Pharma Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

InnoCan Pharma Corporation (INNPF) Company Profile & Overview

InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally. The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes. Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOIris Bincovich

Contact Information

403 777 1519
1015, 926 – 5 Avenue SW, Calgary, AB, T2P 0N7

Company Facts

IPO DateNov 27, 2020
CountryCA
Actively Trading

Frequently Asked Questions

;